Document:

Exhibit
4.2

 

WARRANT
AGREEMENT

 

This
agreement (“Agreement”) is made as of December 30, 2022 between AlphaTime Acquisition Corp, a Cayman Islands exempted
company (“Company”), and American Stock Transfer & Trust Company, a limited purpose trust company, as warrant
agent (the “Warrant Agent”, also referred to herein as the “Transfer Agent”).

 

WHEREAS,
the Company is engaged in a public offering (“Public Offering”) of up to 6,900,000 units (including up to 900,000
units subject to the Over-allotment Option (as defined below)) (“Units”), each Unit comprised of one ordinary share
of the Company, par value $0.0001 per share (“Ordinary Shares”) and one redeemable warrant, where each whole warrant
entitles the holder to purchase one Ordinary Share at a price of $11.50 per share, subject to adjustment as described herein, and, in
connection therewith, will issue and deliver up to 6,900,000 warrants (including up to 900,000 warrants subject to the Over-allotment
Option) (the “Public Warrant” or “Public Warrants”) and 6,900,000 Ordinary Shares (including up to 900,000
Ordinary Shares subject to the Over-allotment Option) (the “Public Share” or “Public Shares”) to
the public investors in connection with the Public Offering; and

 

WHEREAS,
the Company has filed with the Securities and Exchange Commission (the “SEC”) a Registration Statement on Form S-1,
File No. 333-268696 (“Registration Statement”), and a prospectus (the “Prospectus”) for the registration,
under the Securities Act of 1933, as amended (“Act”), of, among other securities, the Units, the Unit Purchase Option,
the Public Warrants and the Ordinary Shares included in the Units; and

 

WHEREAS,
the Company has received binding commitments from Alphamade Holding LP (the “Sponsor”) to purchase up to an aggregate
of 409,200 private units (including up to 38,700 private units subject to the Over- allotment Option) (“Private Units”)
bearing the legend set forth in Exhibit B hereto, in a private placement transaction to occur simultaneously with the consummation
of the Public Offering, with each Private Unit consisting of one Ordinary Share (“Private Shares”) and one redeemable
warrant (“Private Warrants”); and

 

WHEREAS,
simultaneously with the consummation of the Public Offering, the Company has agreed to sell to Chardan Capital Markets, LLC, for $100.00,
an option to purchase up to a total of 68,000 units exercisable, in whole or in part, at $11.50 per unit, commencing on the consummation
of the initial business combination and expiring five years from the effective date of the Public Offering (the “Unit Purchase
Option”). The warrants underlying the units in the Unit Purchase Option shall be referred to herein as (the “Purchase
Option Warrants”); and

 

WHEREAS,
in order to finance the Company’s transaction costs in connection with an intended initial Business Combination (as defined
below), the Sponsor or affiliates of the Sponsor or certain of the Company’s officers and directors may, but are not obligated
to, loan the Company funds as the Company may require, of which up to $300,000 of such loans may be convertible into working capital
units, at the price of $10.00 per unit at the option of the lenders (the “Working Capital Units”). Each Working
Capital Unit shall consist of one Ordinary Share (“Working Capital Shares”) and one redeemable warrant
(“Working Capital Warrants”); and

 

WHEREAS,
following the consummation of the Public Offering, the Company may issue additional warrants (“Post IPO Warrants”
collectively with the Public Warrants, Private Warrants, Working Capital Warrants, and Purchase Option Warrants, the “Warrants”)
in connection with, or following the consummation by the Company of, an initial business combination; and

 

WHEREAS,
the Company desires the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing to so act, in connection with
the issuance, registration, transfer, exchange, redemption, and exercise of the Warrants; and

 

WHEREAS,
the Company desires to provide for the form and provisions of the Warrants, the terms upon which they shall be issued and exercised,
and the respective rights, limitation of rights, and immunities of the Company, the Warrant Agent, and the holders of the Warrants; and

 

WHEREAS,
all acts and things have been done and performed which are necessary to make the Warrants, when executed on behalf of the Company and
countersigned by or on behalf of the Warrant Agent, as provided herein, the valid, binding, and legal obligations of the Company, and
to authorize the execution and delivery of this Agreement.

 

    	 

    	 

    

 

NOW,
THEREFORE, in consideration of the mutual agreements herein contained, the parties hereto agree as follows:

 

1.
Appointment of Warrant Agent. The Company hereby appoints the Warrant Agent to act as agent for the Company for the Warrants,
and the Warrant Agent hereby accepts such appointment and agrees to perform the same in accordance with the terms and conditions set
forth in this Agreement.

 

		2.	Warrants.

 

2.1.
Form of Warrant. Each Warrant shall be issued in registered form only, shall be in substantially the form of Exhibit A
hereto, the provisions of which are incorporated herein and shall be signed by, or bear the facsimile signature of, the Chairman of the
Board of Directors or Chief Executive Officer and the Chief Financial Officer, Treasurer, Secretary or Assistant Secretary of the Company
and shall bear a facsimile of the Company’s seal. In the event the person whose facsimile signature has been placed upon any Warrant
shall have ceased to serve in the capacity in which such person signed the Warrant before such Warrant is issued, it may be issued with
the same effect as if he or she had not ceased to be such at the date of issuance.

 

2.2.
Uncertificated Warrants. Notwithstanding anything herein to the contrary, any Warrant, or portion thereof, may be issued as part
of, and be represented by, a Unit, and any Warrant may be issued in uncertificated or book-entry form through the Warrant Agent and/or
the facilities of The Depository Trust Company or other book- entry depositary system, in each case as determined by the Board of Directors
of the Company or by an authorized committee thereof. Any Warrant so issued shall have the same terms, force and effect as a certificated
Warrant that has been duly countersigned by the Warrant Agent in accordance with the terms of this Agreement.

 

2.3.
Effect of Countersignature. Except with respect to uncertificated Warrants as described above, unless and until countersigned
by the Warrant Agent pursuant to this Agreement, a Warrant shall be invalid and of no effect and may not be exercised by the holder thereof.

 

		2.4.	Registration.

 

2.4.1.
Warrant Register. The Warrant Agent shall maintain books (“Warrant Register”) for the registration of original
issuance and the registration of transfer of the Warrants. Upon the initial issuance of the Warrants, the Warrant Agent shall issue and
register the Warrants in the names of the respective holders thereof in such denominations and otherwise in accordance with instructions
delivered to the Warrant Agent by the Company.

 

2.4.2.
Registered Holder. Prior to due presentment for registration of transfer of any Warrant, the Company and the Warrant Agent may
deem and treat the person in whose name such Warrant is then registered in the Warrant Register (“registered holder”)
as the absolute owner of such Warrant and of each Warrant represented thereby (notwithstanding any notation of ownership or other writing
on the Warrant certificate made by anyone other than the Company or the Warrant Agent), for the purpose of any exercise thereof, and
for all other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary.

 

2.5.
Detachability of Warrants. The securities comprising the Units will not be separately transferable until the 90th day following
the date of the Prospectus or, if such 90th day is not on a day, other than Saturday, Sunday or federal holiday, on which banks in New
York City are generally open for normal business (a “Business Day”), then on the immediately succeeding Business Day
following such date, or earlier with the consent of Chardan Capital Markets, LLC (the “Representative”), but in no
event will the Representative allow separate trading of the securities comprising the Units until (i) the Company has filed a Current
Report on Form 8-K which includes an audited balance sheet reflecting the receipt by the Company of the gross proceeds of the Public
Offering including the proceeds received by the Company from the exercise of the underwriters’ over-allotment option in the Public
Offering (the “Over-allotment Option”), if the Over-allotment Option is exercised prior to the filing of the Form
8-K, and (ii) the Company has issued a press release announcing when such separate trading shall begin (the “Detachment Date”);
provided that no fractional Warrants will be issued upon separation of the Units and only whole Warrants will trade.

 

    	2

    	 

    

 

2.6.
Private Warrant, Purchase Option Warrants, Post IPO Warrants, and Working Capital Warrant Attributes. The Private Warrants, Purchase
Option Warrants, Post IPO Warrants and Working Capital Warrants will be identical to and issued in the same form as the Public Warrants,
subject to any exceptions noted in the Registration Statement.

 

		3.	Terms
                                            and Exercise of Warrants

 

3.1.
Warrant Price. Each whole Warrant shall, when countersigned by the Warrant Agent (except with respect to uncertificated Warrants),
entitle the registered holder thereof, subject to the provisions of such Warrant and of this Agreement, to purchase from the Company
the number of Ordinary Shares stated therein, at the price of $11.50 per share, subject to the adjustments provided in Section 4
hereof and in the last sentence of this Section 3.1. The term “Warrant Price” as used in this Agreement refers to
the price per share at which the Ordinary Shares may be purchased at the time a Warrant is exercised. The Company in its sole discretion
may lower the Warrant Price at any time prior to the Expiration Date (as defined below) for a period of not less than twenty (20) Business
Days; provided, that the Company shall provide at least twenty (20) days’ prior written notice of such reduction to registered
holders of the Warrants and, provided further that any such reduction shall be applied consistently to all of the Warrants.

 

3.2.
Duration of Warrants. A Warrant may be exercised only during the period commencing on 30 days after the consummation by the Company
of a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination
with one or more businesses or entities (“Business Combination”) (as described more fully in the Registration Statement)
and terminating at 5:00 p.m., New York City time on the earlier to occur of (i) five years from the consummation of a Business Combination,
(ii) the Redemption Date as provided in Section 6.2 of this Agreement and (iii) the liquidation of the Company (“Expiration
Date”), provided, however, that the Warrants issued to Chardan Capital Markets, LLC will not be exercisable more than five
years after the commencement of sales in accordance with FINRA Rule 5110(g)(8). The period of time from the date the Warrants will first
become exercisable until the expiration of the Warrants shall hereafter be referred to as the “Exercise Period.” Except with
respect to the right to receive the Redemption Price (as set forth in Section 6 hereunder), as applicable, each Warrant not exercised
on or before the Expiration Date shall become void, and all rights thereunder and all rights in respect thereof under this Agreement
shall cease at 5:00 p.m., New York City time, on the Expiration Date. The Company in its sole discretion may extend the duration of the
Warrants by delaying the Expiration Date; provided, however, that the Company will provide at least twenty (20) days’ prior written
notice of any such extension to registered holders and, provided further that any such extension shall be applied consistently to all
of the Warrants.

 

		3.3.	Exercise
                                            of Warrants.

 

3.3.1.
Payment. Subject to the provisions of the Warrant and this Agreement, a Warrant, when countersigned by the Warrant Agent, may
be exercised by the registered holder thereof by surrendering it, at the office of the Warrant Agent, or at the office of its successor
as Warrant Agent, in the Borough of Manhattan, City and State of New York, with the subscription form, as set forth in the Warrant, duly
executed, and by paying in full the Warrant Price for each full Ordinary Share as to which the Warrant is exercised and any and all applicable
taxes due in connection with the exercise of the Warrant, the exchange of the Warrant for the Ordinary Shares and the issuance of such
Ordinary Shares, as follows:

 

		(a)	in
                                            lawful money of the United States, by good certified check or wire payable to

the
Warrant Agent; or

 

(b)
in the event of redemption pursuant to Section 6 hereof in which the Company’s management has elected to require all holders
of Warrants to exercise such Warrants on a “cashless basis,” by surrendering the Warrants for that number of Ordinary Shares
equal to the quotient obtained by dividing (x) the product of the number of Ordinary Shares underlying the Warrants, multiplied by the
excess of the “Fair Market Value”, as defined in this subsection 3.3.1(b), over the Warrant Price by (y) the Fair Market
Value. Solely for purposes of this subsection 3.3.1(b) and Section 6.2, the “Fair Market Value” shall mean the average last
reported sale price of the Ordinary Shares for the ten (10) trading days ending on the third (3rd) trading day prior to the date on which
the notice of redemption is sent to the holders of the Warrants, pursuant to Section 6 hereof; or

 

    	3

    	 

    

 

(c)
in the event the registration statement required by Section 7.4 hereof is not effective and current within sixty (60) Business
Days after the closing of a Business Combination, by surrendering such Warrants for that number of Ordinary Shares equal to the quotient
obtained by dividing (x) the product of the number of Ordinary Shares underlying the Warrants, multiplied by the difference between the
exercise price of the Warrants and the “Fair Market Value” by (y) the Fair Market Value; provided, however, that no cashless
exercise shall be permitted unless the Fair Market Value is equal to or higher than the exercise price. Solely for purposes of this Section
3.3.1(c), the “Fair Market Value” shall mean the average reported last sale price of the Ordinary Shares for the ten
(10) trading days ending on the third (3rd) trading day prior to the date on which the notice of exercise of the Warrant is sent to the
Warrant Agent.

 

3.3.2.
Issuance of Ordinary Shares. As soon as practicable after the exercise of any Warrant and the clearance of the funds in payment
of the Warrant Price (if any), the Company shall issue to the registered holder of such Warrant a certificate or certificates, or book
entry position, for the number of Ordinary Shares to which he, she or it is entitled, registered in such name or names as may be directed
by him, her or it, and if such Warrant shall not have been exercised in full, a new countersigned Warrant, or book entry position, for
the number of shares as to which such Warrant shall not have been exercised. Notwithstanding the foregoing, in no event will the Company
be required to net cash settle the Warrant exercise. No Warrant shall be exercisable for cash and the Company shall not be obligated
to issue Ordinary Shares upon exercise of a Warrant unless the Ordinary Shares issuable upon such Warrant exercise has been registered,
qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the Warrants. In the
event that the condition in the immediately preceding sentence is not satisfied with respect to a Warrant, the holder of such Warrant
shall not be entitled to exercise such Warrant for cash and such Warrant may have no value and expire worthless, in which case the purchaser
of a Unit containing such Public Warrants shall have paid the full purchase price for the Unit solely for the Ordinary Shares underlying
such Unit. Warrants may not be exercised by, or securities issued to, any registered holder in any state in which such exercise would
be unlawful.

 

3.3.3.
Valid Issuance. All Ordinary Shares issued upon the proper exercise of a Warrant in conformity with this Agreement shall be validly
issued, fully paid and nonassessable.

 

3.3.4.
Date of Issuance. Each person in whose name any book entry position or certificate for Ordinary Shares is issued shall for all
purposes be deemed to have become the holder of record of such shares on the date on which the Warrant, or book entry position representing
such Warrant, was surrendered and payment of the Warrant Price was made, irrespective of the date of delivery of such certificate, except
that, if the date of such surrender and payment is a date when the share transfer books of the Company or book entry system of the Warrant
Agent are closed, such person shall be deemed to have become the holder of such shares at the close of business on the next succeeding
date on which the share transfer books or book entry system are open.

 

3.3.5.
Maximum Percentage. A holder of a Warrant may notify the Company in writing in the event it elects to be subject to the provisions
contained in this subsection 3.3.5; however, no holder of a Warrant shall be subject to this subsection 3.3.5 unless he, she or it makes
such election. If the election is made by a holder, the Warrant Agent shall not effect the exercise of the holder’s Warrant, and
such holder shall not have the right to exercise such Warrant, to the extent that after giving effect to such exercise, such person (together
with such person’s affiliates), to the Warrant Agent’s actual knowledge, would beneficially own in excess of 9.8% (the “Maximum
Percentage”) of the Ordinary Shares outstanding immediately after giving effect to such exercise. For purposes of the foregoing
sentence, the aggregate number of Ordinary Shares beneficially owned by such person and its affiliates shall include the number of Ordinary
Shares issuable upon exercise of the Warrant with respect to which the determination of such sentence is being made, but shall exclude
Ordinary Shares that would be issuable upon (x) exercise of the remaining, unexercised portion of the Warrant beneficially owned by such
person and its affiliates and (y) exercise or conversion of the unexercised or unconverted portion of any other securities of the Company
beneficially owned by such person and its affiliates (including, without limitation, any convertible notes or convertible preferred stock
or warrants) subject to a limitation on conversion or exercise analogous to the limitation contained herein. Except as set forth in the
preceding sentence, for purposes of this paragraph, beneficial ownership shall be calculated in accordance with Section 13(d) of the
Securities Exchange Act of 1934, as amended (the “Exchange Act”). For purposes of the Warrant, in determining the
number of outstanding Ordinary Shares, the holder may rely on the number of outstanding Ordinary Shares as reflected in (1) the Company’s
most recent annual report on Form 10- K, quarterly report on Form 10-Q, current report on Form 8-K or other public filing with the SEC
as the case may be, (2) a more recent public announcement by the Company or (3) any other notice by the Company or the Transfer Agent
setting forth the number of Ordinary Shares outstanding. For any reason at any time, upon the written request of the holder of the Warrant,
the Company shall, within two (2) Business Days, confirm orally and in writing to such holder the number of Ordinary Shares then outstanding.
In any case, the number of outstanding Ordinary Shares shall be determined after giving effect to the conversion or exercise of equity
securities of the Company by the holder and its affiliates since the date as of which such number of outstanding Ordinary Shares was
reported. By written notice to the Company, the holder of a Warrant may from time to time increase or decrease the Maximum Percentage
applicable to such holder to any other percentage specified in such notice; provided, however, that any such increase shall not be effective
until the sixty-first (61st) day after such notice is delivered to the Company.

 

    	4

    	 

    

 

		4.	Adjustments.

 

4.1.
Stock Dividends; Split Ups. If after the date hereof, and subject to the provisions of Section 4.6 below, the number of
outstanding Ordinary Shares is increased by a stock dividend payable in Ordinary Shares, or by a split up of Ordinary Shares, or other
similar event, then, on the effective date of such stock dividend, split up or similar event, the number of Ordinary Shares issuable
on exercise of each Warrant shall be increased in proportion to such increase in outstanding Ordinary Shares.

 

4.2.
Aggregation of Shares. If after the date hereof, the number of outstanding Ordinary Shares is decreased by a consolidation, combination,
reverse stock split or reclassification of Ordinary Shares or other similar event, then, on the effective date of such consolidation,
combination, reverse stock split, reclassification or similar event, the number of Ordinary Shares issuable on exercise of each Warrant
shall be decreased in proportion to such decrease in outstanding Ordinary Shares.

 

4.3.
Extraordinary Dividends. If the Company, at any time while the Warrants are outstanding and unexpired, shall pay a dividend or
make a distribution in cash, securities or other assets to the holders of the Ordinary Shares or other shares of the Company’s
capital stock into which the Warrants are convertible (an “Extraordinary Dividend”), then the Warrant Price shall
be decreased, effective immediately after the effective date of such Extraordinary Dividend, by the amount of cash and the fair market
value (as determined by the Company’s Board of Directors, in good faith) of any securities or other assets paid in respect of such
Extraordinary Dividend divided by all outstanding shares of the Company at such time (whether or not any shareholders waived their right
to receive such dividend); provided, however, that none of the following shall be deemed an Extraordinary Dividend for purposes of this
provision: (a) any adjustment described in subsection 4.1 above, (b) any cash dividends or cash distributions which, when combined
on a per share basis with all other cash dividends and cash distributions paid on the Ordinary Shares during the 365- day period ending
on the date of declaration of such dividend or distribution does not exceed $0.50 per share (taking into account all of the outstanding
shares of the Company at such time (whether or not any shareholders waived their right to receive such dividend) and as adjusted to appropriately
reflect any of the events referred to in other subsections of this Section 4 and excluding cash dividends or cash distributions
that resulted in an adjustment to the Warrant Price or to the number of Ordinary Shares issuable on exercise of each Warrant) but only
with respect to the amount of the aggregate cash dividends or cash distributions equal to or less than $0.50, (c) any payment to satisfy
the conversion rights of the holders of the Ordinary Shares in connection with a proposed initial Business Combination or certain amendments
to the Company’s Amended and Restated Certificate of Incorporation (as described in the Registration Statement) or (d) any payment
in connection with the Company’s liquidation and the distribution of its assets upon its failure to consummate a Business Combination.
Solely for purposes of illustration, if the Company, at a time while the Warrants are outstanding and unexpired, pays a cash dividend
of $0.35 and previously paid an aggregate of $0.40 of cash dividends and cash distributions on the Ordinary Shares during the 365- day
period ending on the date of declaration of such $0.35 dividend, then the Warrant Price will be decreased, effectively immediately after
the effective date of such $0.35 dividend, by $0.25 (the absolute value of the difference between $0.75 (the aggregate amount of all
cash dividends and cash distributions paid or made in such 365-day period, including such $0.35 dividend) and $0.50 (the greater of (x)
$0.50 and (y) the aggregate amount of all cash dividends and cash distributions paid or made in such 365-day period prior to such $0.35
dividend)).

 

    	5

    	 

    

 

4.4.
Adjustments in Exercise Price. Whenever the number of Ordinary Shares purchasable upon the exercise of the Warrants is adjusted,
as provided in Sections 4.1 and 4.2 above, the Warrant Price shall be adjusted (to the nearest cent) by multiplying such
Warrant Price immediately prior to such adjustment by a fraction (x) the numerator of which shall be the number of Ordinary Shares purchasable
upon the exercise of the Warrants immediately prior to such adjustment, and (y) the denominator of which shall be the number of Ordinary
Shares so purchasable immediately thereafter.

 

4.5.
Replacement of Securities upon Reorganization, etc. In case of any reclassification or reorganization of the outstanding Ordinary
Shares (other than a change covered by Section 4.1, 4.2 or 4.3 hereof or that solely affects the par value of the
Ordinary Shares), or in the case of any merger or consolidation of the Company with or into another corporation (other than a consolidation
or merger in which the Company is the continuing corporation and that does not result in any reclassification or reorganization of the
outstanding Ordinary Shares), or in the case of any sale or conveyance to another corporation or entity of the assets or other property
of the Company as an entirety or substantially as an entirety in connection with which the Company is dissolved, the Warrant holders
shall thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the Warrants and
in lieu of the Ordinary Shares of the Company immediately theretofore purchasable and receivable upon the exercise of the rights represented
thereby, the kind and amount of shares of stock or other securities or property (including cash) receivable upon such reclassification,
reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, that the Warrant holder would have
received if such Warrant holder had exercised his, her or its Warrant(s) immediately prior to such event. If any reclassification also
results in a change in the Ordinary Shares covered by Section 4.1, 4.2 or 4.3, then such adjustment shall be made
pursuant to Sections 4.1, 4.2, 4.3, 4.4 and this Section 4.5. The provisions of this Section 4.5
shall similarly apply to successive reclassifications, reorganizations, mergers or consolidations, sales or other transfers. In no
event will the Warrant Price be reduced to less than the par value per share issuable upon exercise of the Warrant.

 

4.6.
Issuance in connection with a Business Combination. If, in connection with a Business Combination, the Company (a) issues additional
Ordinary Shares or equity-linked securities at an issue price or effective issue price of less than $9.50 per share (with such issue
price or effective issue price as determined by the Company’s Board of Directors, in good faith, and in the case of any such issuance
to the Sponsor, the initial shareholders or their affiliates, without taking into account any of the Company’s ordinary shares,
par value $0.0001 per share, issued prior to the Public Offering and held by the initial shareholders or their affiliates, as applicable,
prior to such issuance) (the “Newly Issued Price”), (b) the aggregate gross proceeds from such issuances represent
more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Business Combination on the date of
the consummation of such Business Combination (net of redemptions), and (c) the Market Value (as defined below) is below $9.50 per share,
then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i) the Market Value
and (ii) Newly Issued Price, and the $16.50 per share Redemption Trigger Price (as defined below) will be adjusted (to the nearest cent)
to be equal to 165% of the Market Value and the Newly Issued Price. Solely for purposes of this Section 4.6, the “Market
Value” shall mean the volume weighted average trading price of the Ordinary Shares during the twenty (20) trading day period starting
on the trading day prior to the date of the consummation of the Business Combination.

 

4.7.
Notices of Changes in Warrant. Upon every adjustment of the Warrant Price or the number of shares issuable upon exercise of a
Warrant, the Company shall give written notice thereof to the Warrant Agent, which notice shall state the Warrant Price resulting from
such adjustment and the increase or decrease, if any, in the number of shares purchasable at such price upon the exercise of a Warrant,
setting forth in reasonable detail the method of calculation and the facts upon which such calculation is based. Upon the occurrence
of any event specified in Sections 4.1, 4.2, 4.3, 4.4, 4.5, or 4.6, then, in any such event,
the Company shall give written notice to each Warrant holder, at the last address set forth for such holder in the Warrant Register,
of the record date or the effective date of the event. Failure to give such notice, or any defect therein, shall not affect the legality
or validity of such event.

 

4.8.
No Fractional Warrants or Shares. Notwithstanding any provision contained in this Agreement to the contrary, the Company shall
not issue fractional shares upon exercise of Warrants. If, by reason of any adjustment made pursuant to this Section 4, the holder
of any Warrant would be entitled, upon the exercise of such Warrant, to receive a fractional interest in a share, the Company shall,
upon such exercise, round up to the nearest whole number of Ordinary Shares to be issued to the Warrant holder.

 

    	6

    	 

    

 

4.9.
Form of Warrant. The form of Warrant need not be changed because of any adjustment pursuant to this Section 4, and Warrants
issued after such adjustment may state the same Warrant Price and the same number of shares as is stated in the Warrants initially issued
pursuant to this Agreement. However, the Company may at any time in its sole discretion make any change in the form of Warrant that the
Company may deem appropriate and that does not affect the substance thereof, and any Warrant thereafter issued or countersigned, whether
in exchange or substitution for an outstanding Warrant or otherwise, may be in the form as so changed.

 

4.10.
Other Events. In case any event shall occur affecting the Company as to which none of the provisions of preceding subsections
of this Section 4 are strictly applicable, but which would require an adjustment to the terms of the Warrants in order to (i)
avoid an adverse impact on the Warrants and (ii) effectuate the intent and purpose of this Section 4, then, in each such case,
the Company shall appoint a firm of independent public accountants, investment banking or other appraisal firm of recognized national
standing, which shall give its opinion as to whether or not any adjustment to the rights represented by the Warrants is necessary to
effectuate the intent and purpose of this Section 4 and, if they determine that an adjustment is necessary, the terms of such
adjustment. The Company shall adjust the terms of the Warrants in a manner that is consistent with any adjustment recommended in such
opinion.

 

		4.11.	[Reserved].

 

		5.	Transfer
                                            and Exchange of Warrants.

 

5.1.
Registration of Transfer. The Warrant Agent shall register the transfer, from time to time, of any outstanding Warrant upon the
Warrant Register, upon surrender of such Warrant for transfer, properly endorsed with signatures, in the case of certificated Warrants,
properly guaranteed and accompanied by appropriate instructions for transfer. Upon any such transfer, a new Warrant representing an equal
aggregate number of Warrants shall be issued and the old Warrant shall be cancelled by the Warrant Agent. In the case of certificated
Warrants, the Warrants so cancelled shall be delivered by the Warrant Agent to the Company from time to time upon request.

 

5.2.
Procedure for Surrender of Warrants. Warrants may be surrendered to the Warrant Agent, either in certificated form or in book
entry position, together with a written request for exchange or transfer, and thereupon the Warrant Agent shall issue in exchange therefor
one or more new Warrants, or book entry positions, as requested by the registered holder of the Warrants so surrendered, representing
an equal aggregate number of Warrants; provided, however, that in the event that a Warrant surrendered for transfer bears a restrictive
legend, the Warrant Agent shall not cancel such Warrant and issue new Warrants in exchange therefor until the Warrant Agent has received
an opinion of counsel for the Company stating that such transfer may be made and indicating whether the new Warrants must also bear a
restrictive legend.

 

5.3.
Fractional Warrants. The Warrant Agent shall not be required to effect any registration of transfer or exchange which will result
in the issuance of a warrant certificate or book-entry position for a fraction of a warrant, except as part of the Units.

 

5.4.
Service Charges. No service charge shall be made for any exchange or registration of transfer of Warrants.

 

5.5.
Warrant Execution and Countersignature. The Warrant Agent is hereby authorized to countersign and to deliver, in accordance with
the terms of this Agreement, the Warrants required to be issued pursuant to the provisions of this Section 5, and the Company,
whenever required by the Warrant Agent, will supply the Warrant Agent with Warrants duly executed on behalf of the Company for such purpose.

 

    	7

    	 

    

 

5.6.
Private Warrants, Purchase Option Warrants, Post IPO Warrants, and Working Capital Warrants. The Warrant Agent shall not register
any transfer of Private Warrants, Purchase Option Warrants, Post IPO Warrants, or Working Capital Warrants until after the consummation
by the Company of an initial Business Combination, except for transfers (i) to our officers or directors, any affiliates or family members
of any of our officers or directors, any members of our founders, or any affiliate of our founders, (ii) to a holder’s stockholders
or members upon the holder’s liquidation, in each case if the holder is an entity, (iii) in the case of an individual, by gift
to a member of the individual’s immediate family, to a trust, the beneficiary of which is a member of the individual’s immediate
family or an affiliate of such person, or to a charitable organization, (iv) in the case of an individual, by virtue of laws of descent
and distribution upon death of the individual, (v) in the case of an individual, pursuant to a qualified domestic relations order, (vi)
to the Company for no value for cancellation in connection with the consummation of a Business Combination, (vii) by private sales or
transfers made in connection with the consummation of a business combination at prices no greater than the price at which the Warrants
were originally purchased, (viii) by virtue of the laws of the Cayman Islands or the memorandum and articles of association of our sponsor
upon dissolution of the sponsor, (ix) in the event of the Company’s liquidation prior to its consummation of an initial Business
Combination or (x) in the event that, subsequent to the consummation of an initial Business Combination, the Company completes a liquidation,
merger, capital stock exchange or other similar transaction which results in all of the Company’s stockholders having the right
to exchange their Ordinary Shares for cash, securities or other property, in each case (except for clauses (vi), (ix) or (x) or with
the Company’s prior written consent) on the condition that prior to such registration for transfer, the Warrant Agent shall be
presented with written documentation pursuant to which each transferee (each, a “Permitted Transferee”) or the trustee
or legal guardian for such Permitted Transferee agrees to be bound by the transfer restrictions contained in this Agreement and any other
applicable agreement the transferor is bound by.

 

5.7.
Transfers prior to Detachment. Prior to the Detachment Date, the Public Warrants may be transferred or exchanged only together
with the Unit in which such Warrant is included, and only for the purpose of effecting, or in conjunction with, a transfer or exchange
of such Unit. Furthermore, each transfer of a Unit on the register relating to such Units shall operate also to transfer the Warrants
included in such Unit. Notwithstanding the foregoing, the provisions of this Section 5.7 shall have no effect on any transfer
of Warrants on or after the Detachment Date.

 

		6.	Redemption.

 

6.1.
Redemption. Not less than all of the outstanding Warrants may be redeemed, at the option of the Company, at any time during the
Exercise Period, at the office of the Warrant Agent, upon the notice referred to in Section 6.2, at the price of $0.01 per Warrant
(“Redemption Price”), provided that the last sales price of the Ordinary Shares equals or exceeds $16.50 per share
(subject to adjustment in accordance with Section 4 hereof) (the “Redemption Trigger Price”), on each of twenty
(20) trading days within any thirty (30) trading day period commencing after the Warrants become exercisable and ending on the third
trading day prior to the date on which notice of redemption is given and provided that there is an effective registration statement covering
the Ordinary Shares issuable upon exercise of the Warrants, and a current prospectus relating thereto, available throughout the 30- day
redemption or the Company has elected to require the exercise of the Warrants on a “cashless basis” pursuant to subsection
3.3.1(b); provided, however, that if and when the Public Warrants become redeemable by the Company, the Company may not exercise
such redemption right if the issuance of Ordinary Shares upon exercise of the Public Warrants is not exempt from registration or qualification
under applicable state blue sky laws or the Company is unable to effect such registration or qualification.

 

6.2.
Date Fixed for, and Notice of, Redemption. In the event the Company shall elect to redeem all of the Warrants that are subject
to redemption, the Company shall fix a date for the redemption (the “Redemption Date”). Notice of redemption shall
be mailed by first class mail, postage prepaid, by the Company not less than thirty (30) days prior to the Redemption Date to the registered
holders of the Warrants to be redeemed at their last addresses as they shall appear on the registration books. Any notice mailed in the
manner herein provided shall be conclusively presumed to have been duly given whether or not the registered holder received such notice.

 

6.3.
Exercise After Notice of Redemption. The Public Warrants may be exercised, for cash (or on a “cashless basis” in accordance
with Section 3 of this Agreement) at any time after notice of redemption shall have been given by the Company pursuant to Section
6.2 hereof and prior to the Redemption Date. In the event the Company determines to require all holders of Public Warrants to exercise
their Warrants on a “cashless basis” pursuant to Section 3.3.1(b), the notice of redemption will contain the information
necessary to calculate the number of Ordinary Shares to be received upon exercise of the Warrants, including the “Fair Market Value”
in such case. On and after the Redemption Date, the record holder of the Warrants shall have no further rights except to receive, upon
surrender of the Warrants, the Redemption Price.

 

    	8

    	 

    

 

		7.	Other
                                            Provisions Relating to Rights of Holders of Warrants.

 

7.1.
No Rights as Stockholder. A Warrant does not entitle the registered holder thereof to any of the rights of a stockholder of the
Company, including, without limitation, the right to receive dividends, or other distributions, exercise any preemptive rights to vote
or to consent or to receive notice as stockholders in respect of the meetings of stockholders or the election of directors of the Company
or any other matter.

 

7.2.
Lost, Stolen, Mutilated, or Destroyed Warrants. If any Warrant is lost, stolen, mutilated, or destroyed, the Company and the Warrant
Agent may on such terms as to indemnity or otherwise as they may in their discretion impose (which shall, in the case of a mutilated
Warrant, include the surrender thereof), issue a new Warrant of like denomination, tenor, and date as the Warrant so lost, stolen, mutilated,
or destroyed. Any such new Warrant shall constitute a substitute contractual obligation of the Company, whether or not the allegedly
lost, stolen, mutilated, or destroyed Warrant shall be at any time enforceable by anyone.

 

7.3.
Reservation of Ordinary Shares. The Company shall at all times reserve and keep available a number of its authorized but unissued
Ordinary Shares that will be sufficient to permit the exercise in full of all outstanding Warrants issued pursuant to this Agreement.

 

7.4.
Registration of Ordinary Shares. The Company agrees that as soon as practicable after the closing of its initial Business Combination,
but in no event later than twenty (20) Business Days after the closing of its initial Business Combination, it shall use its best efforts
to file with the SEC a registration statement for the registration, under the Act, of the Ordinary Shares issuable upon exercise of the
Warrants, and it shall use its best efforts to take such action as is necessary to register or qualify for sale, in those states in which
the Warrants were initially offered by the Company and in those states where holders of Warrants then reside, the Ordinary Shares issuable
upon exercise of the Warrants, to the extent an exemption is not available. The Company will use its best efforts to cause the same to
become effective and to maintain the effectiveness of such registration statement until the expiration of the Warrants in accordance
with the provisions of this Agreement. If any such registration statement has not been declared effective by the 60th Business Day following
the closing of the Business Combination, holders of the Warrants shall have the right, during the period beginning on the 61st Business
Day after the closing of the Business Combination and ending upon such registration statement being declared effective by the SEC, and
during any other period when the Company shall fail to have maintained an effective registration statement covering the Ordinary Shares
issuable upon exercise of the Warrants, to exercise such Warrants on a “cashless basis” as determined in accordance with
Section 3.3.1(c). The Company shall provide the Warrant Agent with an opinion of counsel for the Company (which shall be an outside
law firm with securities law experience) stating that (i) the exercise of the Warrants on a cashless basis in accordance with this Section
7.4 is not required to be registered under the Act and (ii) the Ordinary Shares issued upon such exercise will be freely tradable
under U.S. federal securities laws by anyone who is not an affiliate (as such term is defined in Rule 144 under the Act) of the Company
and, accordingly, will not be required to bear a restrictive legend. For the avoidance of any doubt, unless and until all of the Warrants
have been exercised on a cashless basis, the Company shall continue to be obligated to comply with its registration obligations under
the first three sentences of this Section 7.4. The provisions of this Section 7.4 may not be modified, amended, or deleted
without the prior written consent of the Representatives.

 

		8.	Concerning
                                            the Warrant Agent and Other Matters.

 

8.1.
Payment of Taxes. The Company will from time to time promptly pay all taxes and charges that may be imposed upon the Company or
the Warrant Agent in respect of the issuance or delivery of Ordinary Shares upon the exercise of Warrants, but the Company shall not
be obligated to pay any transfer taxes in respect of the Warrants or such shares.

 

    	9

    	 

    

 

8.2.
Resignation, Consolidation, or Merger of Warrant Agent.

 

8.2.1.
Appointment of Successor Warrant Agent. The Warrant Agent, or any successor to it hereafter appointed, may resign its duties and
be discharged from all further duties and liabilities hereunder after giving sixty (60) days’ notice in writing to the Company.
If the office of the Warrant Agent becomes vacant by resignation or incapacity to act or otherwise, the Company shall appoint in writing
a successor Warrant Agent in place of the Warrant Agent. If the Company shall fail to make such appointment within a period of thirty
(30) days after it has been notified in writing of such resignation or incapacity by the Warrant Agent or by the holder of the Warrant
(who shall, with such notice, submit his Warrant for inspection by the Company), then the holder of any Warrant may apply to the Supreme
Court of the State of New York for the County of New York for the appointment of a successor Warrant Agent at the Company’s cost.
Any successor Warrant Agent, whether appointed by the Company or by such court, shall be a corporation organized and existing under the
laws of the State of New York, in good standing and having its principal office in the Borough of Manhattan, City and State of New York,
and authorized under such laws to exercise corporate trust powers and subject to supervision or examination by federal or state authority.
After appointment, any successor Warrant Agent shall be vested with all the authority, powers, rights, immunities, duties, and obligations
of its predecessor Warrant Agent with like effect as if originally named as Warrant Agent hereunder, without any further act or deed;
but if for any reason it becomes necessary or appropriate, the predecessor Warrant Agent shall execute and deliver, at the expense of
the Company, an instrument transferring to such successor Warrant Agent all the authority, powers, and rights of such predecessor Warrant
Agent hereunder; and upon request of any successor Warrant Agent the Company shall make, execute, acknowledge, and deliver any and all
instruments in writing for more fully and effectually vesting in and confirming to such successor Warrant Agent all such authority, powers,
rights, immunities, duties, and obligations.

 

8.2.2.
Notice of Successor Warrant Agent. In the event a successor Warrant Agent shall be appointed, the Company shall give notice thereof
to the predecessor Warrant Agent and the Transfer Agent for the Ordinary Shares not later than the effective date of any such appointment.

 

8.2.3.
Merger or Consolidation of Warrant Agent. Any corporation into which the Warrant Agent may be merged or with which it may be consolidated
or any corporation resulting from any merger or consolidation to which the Warrant Agent shall be a party shall be the successor Warrant
Agent under this Agreement without any further act.

 

8.3.
Fees and Expenses of Warrant Agent.

 

8.3.1.
Remuneration. The Company agrees to pay the Warrant Agent reasonable remuneration for its services as such Warrant Agent hereunder
and will reimburse the Warrant Agent upon demand for all expenditures that the Warrant Agent may reasonably incur in the execution of
its duties hereunder.

 

8.3.2.
Further Assurances. The Company agrees to perform, execute, acknowledge, and deliver or cause to be performed, executed, acknowledged,
and delivered all such further and other acts, instruments, and assurances as may reasonably be required by the Warrant Agent for the
carrying out or performing of the provisions of this Agreement.

 

8.4.
Liability of Warrant Agent.

 

8.4.1.
Reliance on Company Statement. Whenever in the performance of its duties under this Agreement, the Warrant Agent shall deem it
necessary or desirable that any fact or matter be proved or established by the Company prior to taking or suffering any action hereunder,
such fact or matter (unless other evidence in respect thereof be herein specifically prescribed) may be deemed to be conclusively proved
and established by a statement signed by the Chief Executive Officer, Chief Financial Officer, Chief Operating Officer, President, Secretary
or Chairman of the Board of Directors of the Company and delivered to the Warrant Agent. The Warrant Agent may rely upon such statement
for any action taken or suffered in good faith by it pursuant to the provisions of this Agreement.

 

8.4.2.
Indemnity. The Warrant Agent shall be liable hereunder only for its own fraud, gross negligence, willful misconduct or bad faith.
The Company agrees to indemnify the Warrant Agent and save it harmless against any and all liabilities, including judgments, out-of-pocket
costs and reasonable counsel fees, for anything done or omitted by the Warrant Agent in the execution of this Agreement except as a result
of the Warrant Agent’s gross negligence, willful misconduct, or bad faith.

 

8.4.3.
Exclusions. The Warrant Agent shall have no responsibility with respect to the validity of this Agreement or with respect to the
validity or execution of any Warrant (except its countersignature thereof); nor shall it be responsible for any breach by the Company
of any covenant or condition contained in this Agreement or in any Warrant; nor shall it be responsible to make any adjustments required
under the provisions of Section 4 hereof or responsible for the manner, method, or amount of any such adjustment or the ascertaining
of the existence of facts that would require any such adjustment; nor shall it by any act hereunder be deemed to make any representation
or warranty as to the authorization or reservation of any Ordinary Shares to be issued pursuant to this Agreement or any Warrant or as
to whether any Ordinary Shares will, when issued, be valid and fully paid and nonassessable.

 

    	10

    	 

    

 

8.5.
Acceptance of Agency. The Warrant Agent hereby accepts the agency established by this Agreement and agrees to perform the same
upon the terms and conditions herein set forth and among other things, shall account promptly to the Company with respect to Warrants
exercised and concurrently account for, and pay to the Company, all monies received by the Warrant Agent for the purchase of Ordinary
Shares through the exercise of Warrants.

 

		9.	Miscellaneous
                                            Provisions.

 

9.1.
Successors. All the covenants and provisions of this Agreement by or for the benefit of the Company or the Warrant Agent shall
bind and inure to the benefit of their respective successors and assigns.

 

9.2.
Notices. Any notice, statement or demand authorized by this Agreement to be given or made by the Warrant Agent or by the holder
of any Warrant to or on the Company shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by certified
mail or private courier service within five (5) days after deposit of such notice, postage prepaid, addressed (until another address
is filed in writing by the Company with the Warrant Agent), as follows:

 

AlphaTime
Acquisition Corp

500
5th Avenue, Suite 938

New
York, NY 10110

Tel:
(347) 627-0058

 

Any
notice, statement or demand authorized by this Agreement to be given or made by the holder of any Warrant or by the Company to or on
the Warrant Agent shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by certified mail or private
courier service within five days after deposit of such notice, postage prepaid, addressed (until another address is filed in writing
by the Warrant Agent with the Company), as follows:

 

American
Stock Transfer & Trust Company

6201
12th Avenue

Brooklyn,
New York 11219

Attn:
Michelle McLean

Email:
Mmclean@astfinancial.com

 

with
a copy in each case to:

 

Winston
& Strawn LLP

800
Capitol St., Suite 2400

Houston
Texas 77002

Attn:
Michael J. Blankenship

 

9.3.
Applicable Law and Exclusive Forum. The validity, interpretation, and performance of this Agreement and of the Warrants shall
be governed in all respects by the laws of the State of New York, without giving effect to conflicts of law principles that would result
in the application of the substantive laws of another jurisdiction. Subject to applicable law, the Company hereby agrees that any action,
proceeding or claim against it arising out of or relating in any way to this Agreement, including under the Act, shall be brought and
enforced in the courts of the State of New York or the United States District Court for the Southern District of New York, and irrevocably
submits to such jurisdiction, which jurisdiction shall be exclusive forum for any such action, proceeding or claim. The Company hereby
waives any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum. Notwithstanding the foregoing,
the provisions of this paragraph will not apply to suits brought to enforce any liability or duty created by the Exchange Act or any
other claim for which the federal district courts of the United States of America are the sole and exclusive forum.

 

    	11

    	 

    

 

Any
person or entity purchasing or otherwise acquiring any interest in the Warrants shall be deemed to have notice of and to have consented
to the forum provisions in this Section 9.3. If any action, the subject matter of which is within the scope the forum provisions
above, is filed in a court other than a court located within the State of New York or the United States District Court for the Southern
District of New York (a “foreign action”) in the name of any warrant holder, such warrant holder shall be deemed to have
consented to: (x) the personal jurisdiction of the state and federal courts located within the State of New York or the United States
District Court for the Southern District of New York in connection with any action brought in any such court to enforce the forum provisions
(an “enforcement action”), and (y) having service of process made upon such warrant holder in any such enforcement action
by service upon such warrant holder’s counsel in the foreign action as agent for such warrant holder.

 

9.4.
Persons Having Rights under this Agreement. Nothing in this Agreement expressed and nothing that may be implied from any of the
provisions hereof is intended, or shall be construed, to confer upon, or give to, any person or corporation other than the parties hereto
and the registered holders of the Warrants any right, remedy, or claim under or by reason of this Agreement or of any covenant, condition,
stipulation, promise, or agreement hereof. All covenants, conditions, stipulations, promises, and agreements contained in this Agreement
shall be for the sole and exclusive benefit of the parties hereto and their successors and assigns and of the registered holders of the
Warrants.

 

9.5.
Examination of the Warrant Agreement. A copy of this Agreement shall be available at all reasonable times at the office of the
Warrant Agent in the Borough of Manhattan, City and State of New York, for inspection by the registered holder of any Warrant. The Warrant
Agent may require any such holder to submit his Warrant for inspection by it.

 

9.6.
Counterparts. This Agreement may be executed in any number of original or facsimile counterparts and each of such counterparts
shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.

 

9.7.
Effect of Headings. The section headings herein are for convenience only and are not part of this Agreement and shall not affect
the interpretation thereof.

 

9.8.
Amendments. This Agreement may be amended by the parties hereto without the consent of any registered holder for the purpose of
(i) curing any ambiguity or to correct any mistake, including to conform the provisions hereof to the description of the terms of the
Warrants and this Agreement set forth in the Prospectus, or curing, correcting or supplementing any defective provision contained herein,
or (ii) adding or changing any other provisions with respect to matters or questions arising under this Agreement as the parties may
deem necessary or desirable and that the parties deem shall not adversely affect the interest of the registered holders. All other modifications
or amendments, including any amendment to increase the Warrant Price or shorten the Exercise Period, shall require the written consent
or vote of the registered holders of at least a majority of the then outstanding Public Warrants. Notwithstanding the foregoing, (a)
any amendment to the terms of the Private Warrants shall only require the consent of the Company and the holders of a majority of the
Private Warrants and (b) the Company may lower the Warrant Price or extend the duration of the Exercise Period pursuant to Sections
3.1 and 3.2, respectively, without the consent of the registered holders.

 

9.9.
Trust Account Waiver. The Warrant Agent acknowledges and agrees that it shall not make any claims or proceed against the trust
account established by the Company in connection with the Public Offering (as more fully described in the Registration Statement) (“Trust
Account”), including by way of set-off, and shall not be entitled to any funds in the Trust Account under any circumstance.
In the event that the Warrant Agent has a claim against the Company under this Agreement, the Warrant Agent will pursue such claim solely
against the Company and not against the property held in the Trust Account.

 

9.10.
Severability. This Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof
shall not affect the validity or enforceability of this Agreement or of any other term or provision hereof. Furthermore, in lieu of any
such invalid or unenforceable term or provision, the parties hereto intend that there shall be added as a part of this Agreement a provision
as similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable.

 

Exhibit
A – Form of Warrant Certificate

 

Exhibit
B – Legend

 

[Signature
Page Follows]

 

    	12

    	 

    

 

IN
WITNESS WHEREOF, this Agreement has been duly executed by the parties hereto as of the day and year first above written.

 

	 	ALPHATIME
    ACQUISITION CORP
	 	 
	 	By:	/s/
    Dajiang Guo
	 	Name:	Dajiang
    Guo
	 	Title:	Chief
    Executive Officer

 

	 	AMERICAN
    STOCK TRANSFER & TRUST COMPANY, as Warrant Agent
	 	 
	 	By:	/s/
    Michael Legregin
	 	Name:	Michael
    Legregin
	 	Title:	SVP

 

[Signature
Page to Warrant Agreement]

 

    	 

    	 

    

 

EXHIBIT
A

FORM
OF WARRANT CERTIFICATE

 

	NUMBER

    -
	(SEE
                                            REVERSE SIDE FOR LEGEND)

    THIS
    WARRANT WILL BE VOID IF NOT EXERCISED PRIOR TO

    THE
    EXPIRATION DATE (DEFINED BELOW)
	WARRANTS

 

ALPHATIME
ACQUISITION CORP

 

CUSIP

 

WARRANT

 

THIS
CERTIFIES THAT, for value received is the registered holder of a warrant or warrants (the “Warrant(s)”) of AlphaTime
Acquisition Corp, a Cayman Islands Exempted Company (the “Company”), expiring at 5:00 p.m., New York City time, on
the five year anniversary of the Company’s completion of an initial merger, capital stock exchange, asset acquisition, stock purchase,
recapitalization, reorganization or other similar business combination with one or more businesses or entities (a “Business
Combination”) or earlier upon redemption or liquidation, to purchase one fully paid and non-assessable ordinary share, par
value $0.0001 per share (“Shares”), of the Company for each whole Warrant evidenced by this Warrant Certificate. The
Warrant entitles the holder thereof to purchase from the Company, commencing on the later of 30 days after the Company’s completion
of an initial Business Combination or 12 months from the closing of the initial public offering, such number of Shares of the Company
at the Warrant Price (as defined below), upon surrender of this Warrant Certificate and payment of the Warrant Price at the office or
agency of American Stock Transfer & Trust Company (the “Warrant Agent”), but only subject to the conditions set
forth herein and in the Warrant Agreement between the Company and American Stock Transfer & Trust Company. In no event will the Company
be required to net cash settle any warrant exercise. The term “Warrant Price” as used in this Warrant Certificate
refers to the price per Share at which Shares may be purchased at the time the Warrant is exercised. The initial Warrant Price per Share
is equal to $11.50 per share. The Warrant Agreement provides that upon the occurrence of certain events the Warrant Price, the Redemption
Trigger Price (as defined below) and the number of Shares purchasable hereunder, set forth on the face hereof, may, subject to certain
conditions, be adjusted.

 

Upon
any exercise of the Warrant for less than the total number of full Shares provided for herein, there shall be issued to the registered
holder hereof or the registered holder’s assignee a new Warrant Certificate covering the number of Shares for which the Warrant
has not been exercised.

 

Warrant
Certificates, when surrendered at the office or agency of the Warrant Agent by the registered holder in person or by attorney duly authorized
in writing, may be exchanged in the manner and subject to the limitations provided in the Warrant Agreement, but without payment of any
service charge, for another Warrant Certificate or Warrant Certificates of like tenor and evidencing in the aggregate a like number of
Warrants.

 

Upon
due presentment for registration of transfer of the Warrant Certificate at the office or agency of the Warrant Agent, a new Warrant Certificate
or Warrant Certificates of like tenor and evidencing in the aggregate a like number of Warrants shall be issued to the transferee in
exchange for this Warrant Certificate, subject to the limitations provided in the Warrant Agreement, without charge except for any applicable
tax or other governmental charge.

 

The
Company and the Warrant Agent may deem and treat the registered holder as the absolute owner of this Warrant Certificate (notwithstanding
any notation of ownership or other writing hereon made by anyone), for the purpose of any exercise hereof, of any distribution to the
registered holder, and for all other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary.

 

This
Warrant does not entitle the registered holder to any of the rights of a shareholder of the Company.

 

    	Exhibit A- 1

    	 

    

 

The
Company reserves the right to call the Warrant at any time prior to its exercise with a notice of call in writing to the holders of record
of the Warrant, giving at least 30 days’ notice of such call, at any time while the Warrant is exercisable, if the last sale price
of the Shares has been at least $16.50 per share (the “Redemption Trigger Price”) on each of 20 trading days within
any 30 trading day period (the “30-day trading period”) ending on the third business day prior to the date on which
notice of such call is given and if, and only if, there is a current registration statement in effect with respect to the Shares underlying
the Warrants commencing five business days prior to the 30-day trading period and continuing each day thereafter until the date of redemption.
The call price of the Warrants is to be $0.01 per Warrant. Any Warrant either not exercised or tendered back to the Company by the end
of the date specified in the notice of call shall be canceled on the books of the Company and have no further value except for the $0.01
call price.

 

	By		 	 
	 	Chief
    Executive Officer	 	Chief
    Financial Officer

 

SUBSCRIPTION
FORM

 

To
Be Executed by the Registered Holder in Order to Exercise Warrants

 

The
undersigned Registered Holder irrevocably elects to exercise ___________Warrants represented by this Warrant Certificate, and to purchase the Ordinary
Shares issuable upon the exercise of such Warrants, and requests that Certificates for such shares shall be issued in the name of

 

	(PLEASE
    TYPE OR PRINT NAME AND ADDRESS)
	 
	 
	(SOCIAL
    SECURITY OR TAX IDENTIFICATION NUMBER)

 

and
be delivered to

 

 

(PLEASE
PRINT OR TYPE NAME AND ADDRESS)

 

and,
if such number of Warrants shall not be all the Warrants evidenced by this Warrant Certificate, that a new Warrant Certificate for the
balance of such Warrants be registered in the name of, and delivered to, the Registered Holder at the address stated below:

 

	Dated:		 	 
	 		 	(SIGNATURE)
	 	 	 	 
	 		 	 
	 	 	 	(ADDRESS)
	 	 	 	 
	 	 	 	 
	 		 	(TAX
    IDENTIFICATION NUMBER)

 

ASSIGNMENT

 

To
Be Executed by the Registered Holder in Order to Assign Warrants

 

For
Value Received, ___________________________hereby sells, assigns and transfers unto

 

    	Exhibit A- 2

    	 

    

 

	(PLEASE
    TYPE OR PRINT NAME AND ADDRESS)
	 
	 
	(SOCIAL
    SECURITY OR TAX IDENTIFICATION NUMBER)

 

and
be delivered to

 

 

(PLEASE
PRINT OR TYPE NAME AND ADDRESS)

 

________________of
the Warrants represented by this Warrant Certificate, and hereby irrevocably constitutes and appoints ______________Attorney to transfer
this Warrant Certificate on the books of the Company, with full power of substitution in the premises.

 

	Dated:	 	 
		 	(SIGNATURE)

 

The
signature to the assignment of the Subscription Form must correspond to the name written upon the face of this Warrant Certificate in
every particular, without alteration or enlargement or any change whatsoever, and must be guaranteed by a commercial bank or trust company
or a member firm of the NYSE American, Nasdaq, New York Stock Exchange, Pacific Stock Exchange, or Chicago Stock Exchange.

 

	Date:	______________,
    20_________	 	 
	 		 	Signature
	 	

     
	 	 
	 	 	 	 
	 	 	 	 
	 	 

    

    
	 	 
	 		 	(Address)
	 	 	 	 
	 	 	 	 
	 	

     

    
	 	(Tax
    Identification Number)

 

Signature
Guaranteed:

 

 

 

THE
SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT
UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE 17Ad- 15 UNDER THE SECURITIES EXCHANGE
ACT OF 1934, AS AMENDED (OR ANY SUCCESSOR RULE)).

 

    	Exhibit A- 3

    	 

    

 

EXHIBIT
B

LEGEND

 

“THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES
LAWS, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
AND ANY APPLICABLE STATE SECURITIES LAWS OR AN EXEMPTION FROM REGISTRATION IS AVAILABLE. IN ADDITION, SUBJECT TO ANY ADDITIONAL LIMITATIONS
ON TRANSFER DESCRIBED IN THE LETTER AGREEMENT BY AND AMONG ALPHATIME ACQUISITION CORP (THE “COMPANY”), AND THE OTHER PARTIES
THERETO, THE SECURITIES REPRESENTED BY THIS CERTIFICATE MAY NOT BE SOLD OR TRANSFERRED PRIOR TO THE DATE THAT IS THIRTY (30) DAYS AFTER
THE DATE UPON WHICH THE COMPANY COMPLETES ITS INITIAL BUSINESS COMBINATION (AS DEFINED IN SECTION 3 OF THE WARRANT AGREEMENT REFERRED
TO HEREIN) EXCEPT TO A PERMITTED TRANSFEREE (AS DEFINED IN SECTION 5 OF THE WARRANT AGREEMENT) WHO AGREES IN WRITING WITH THE COMPANY
TO BE SUBJECT TO SUCH TRANSFER PROVISIONS.

 

SECURITIES
EVIDENCED BY THIS CERTIFICATE AND ORDINARY SHARES OF THE COMPANY ISSUED UPON EXERCISE OF SUCH SECURITIES SHALL BE ENTITLED TO REGISTRATION
RIGHTS UNDER A REGISTRATION RIGHTS AGREEMENT TO BE EXECUTED BY THE COMPANY.”

 

    	Exhibit B- 1Exhibit
10.1

 

December
30, 2022

 

AlphaTime
Acquisition Corp

500
5th Avenue, Suite 938

New
York, NY 10110

 

Chardan
Capital Markets, LLC

17
State Street, 21st Floor

New
York, NY 10004

 

Re:
Initial Public Offering

 

Ladies
and Gentlemen:

 

This
letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the
“Underwriting Agreement”) entered into by and among AlphaTime Acquisition Corp, a Cayman Islands exempted company
(the “Company”), and Chardan Capital Markets LLC , as representative (the “Representative”)
of the several underwriters (each, an “Underwriter” and collectively, the “Underwriters”),
relating to an underwritten initial public offering (the “Public Offering”), of up to 6,900,000 of the Company’s
units (including up to 900,000 units that may be purchased to cover over-allotments, if any) (the “Units”),
each comprised of one of the Company’s ordinary shares, par value $0.0001 per share (the “Ordinary Shares”),
one redeemable warrant and one right. Each whole warrant (each, a “Warrant”) entitles the holder thereof to
purchase one Ordinary Share at a price of $11.50 per share, subject to adjustment as described in the Prospectus (as defined below).
Each right (a “Right”) entitles the holder to receive one-tenth of one Ordinary Share upon the completion of
an initial business combination (“Business Combination”). The Units will be sold in the Public Offering pursuant
to a registration statement on Form S-1 and prospectus (the “Prospectus”) filed by the Company with the U.S.
Securities and Exchange Commission (the “Commission”) and the Company has applied to have the Units, Ordinary Shares, Warrants
and Rights listed on The Nasdaq Global Market. Certain capitalized terms used herein are defined in paragraph 12 hereof.

 

In
order to induce the Company and the Underwriters to enter into the Underwriting Agreement and to proceed with the Public Offering and
for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, each of Alphamade Holding LP
(the “Sponsor”) and the undersigned individuals, each of whom is a member of the Company’s board of directors
and/or management team (each of the undersigned individuals, an “Insider” and collectively, the “Insiders”),
hereby agrees with the Company as follows:

 

		1.	The
                                            Sponsor and each Insider agrees that if the Company seeks shareholder approval of a proposed
                                            Business Combination, then in connection with such proposed Business Combination, it, he
                                            or she shall (i) vote any Ordinary Shares (as defined below) owned by it, him or her in favor
                                            of any proposed Business Combination (including any proposals recommended by the Company’s
                                            Board of Directors in connection with such Business Combination) and (ii) not redeem any
                                            Ordinary Shares owned by it, him or her in connection with such shareholder approval. If
                                            the Company seeks to consummate a proposed Business Combination by engaging in a tender offer,
                                            the Sponsor and each Insider agrees that it, he or she will not sell or tender any Ordinary
                                            Shares owned by it, him or her in connection therewith.

 

    	 

     

    

 

		2.	The
                                            Sponsor and each Insider hereby agrees that in the event that the Company fails to consummate
                                            a Business Combination within 9 months (or up to 18 months if the Company extends the period
                                            of time to consummate a Business Combination as described in the Registration Statement)
                                            from the closing of the Public Offering, or such later period approved by the Company’s
                                            shareholders in accordance with the Company’s amended and restated memorandum and articles
                                            of association (as it may be amended from time to time, the “Charter”),
                                            the Sponsor and each Insider shall take all reasonable steps to cause the Company to (i)
                                            cease all operations except for the purpose of winding up, (ii) as promptly as reasonably
                                            possible but not more than ten (10) business days thereafter, redeem 100% of the Ordinary
                                            Shares sold as part of the Units in the Public Offering (the “Offering Shares”),
                                            at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the
                                            Trust Account (as defined below), including interest earned on the funds held in the Trust
                                            Account (which interest shall be net of taxes payable and up to $100,000 of interest to pay
                                            dissolution expenses), divided by the number of then outstanding Offering Shares, which redemption
                                            will completely extinguish all Public Shareholders’ (as defined below) rights as shareholders
                                            (including the right to receive further liquidating distributions, if any), and (iii) as
                                            promptly as reasonably possible following such redemption, subject to the approval of the
                                            Company’s remaining shareholders and the Company’s board of directors, dissolve
                                            and liquidate, subject in the case of clauses (ii) and (iii) to the Company’s obligations
                                            under Cayman Islands law to provide for claims of creditors and in all cases subject to the
                                            other requirements of applicable law. The Sponsor and each Insider agrees to not propose
                                            any amendment to the Charter (A) to modify the substance or timing of the Company’s
                                            obligation to allow redemption in connection with our initial business combination or to
                                            redeem 100% of the Offering Shares if the Company does not complete a Business Combination
                                            within the required time period set forth in the Charter or (B) with respect to any other
                                            provision relating to shareholders’ rights or pre-initial Business Combination activity,
                                            unless the Company provides its Public Shareholders with the opportunity to redeem their
                                            Offering Shares upon approval of any such amendment at a per-share price, payable in cash,
                                            equal to the aggregate amount then on deposit in the Trust Account, including interest earned
                                            on the funds held in the Trust Account and not previously released to the Company to pay
                                            its taxes, divided by the number of then outstanding Offering Shares.

 

The
Sponsor and each Insider acknowledges that it, he or she has no right, title, interest or claim of any kind in or to any monies held
in the Trust Account or any other asset of the Company as a result of any liquidation of the Company with respect to the Founder Shares
held by it, him or her. The Sponsor and each Insider hereby further waives, with respect to any Ordinary Shares held by it, him or her,
if any, any redemption rights it, he or she may have in connection with (a) the consummation of a Business Combination, including, without
limitation, any such rights available in the context of a shareholder vote to approve such Business Combination, or (b) a shareholder
vote to approve an amendment to the Charter (A) to modify the substance or timing of the Company’s obligation to allow redemption
in connection with our initial business combination or to redeem 100% of the Offering Shares if the Company has not consummated a Business
Combination within the time period set forth in the Charter or (B) with respect to any other provision relating to shareholders’
rights or pre-initial Business Combination activity or in the context of a tender offer made by the Company to purchase Offering Shares
(although the Sponsor, the Insiders and their respective affiliates shall be entitled to redemption and liquidation rights with respect
to any Offering Shares it or they hold if the Company fails to consummate a Business Combination within the time period set forth in
the Charter).

 

		3.	During
                                            the period commencing on the effective date of the Underwriting Agreement and ending 180
                                            days after such date, the Sponsor and each Insider shall not, without the prior written consent
                                            of the Representative, (i) sell, offer to sell, contract or agree to sell, hypothecate, pledge,
                                            grant any option to purchase or otherwise dispose of or agree to dispose of, directly or
                                            indirectly, or establish or increase a put equivalent position or liquidate or decrease a
                                            call equivalent position within the meaning of Section 16 of the Securities Exchange Act
                                            of 1934, as amended (the “Exchange Act”), and the rules and regulations
                                            of the Commission promulgated thereunder, with respect to, any Units, Ordinary Shares (including,
                                            but not limited to, Founder Shares), Warrants, Rights or any securities convertible into,
                                            or exercisable, or exchangeable for, Ordinary Shares owned by it, him or her, (ii) enter
                                            into any swap or other arrangement that transfers to another, in whole or in part, any of
                                            the economic consequences of ownership of any Units, Ordinary Shares (including, but not
                                            limited to, Founder Shares), Warrants, Rights or any securities convertible into, or exercisable,
                                            or exchangeable for, Ordinary Shares owned by it, him or her, whether any such transaction
                                            is to be settled by delivery of such securities, in cash or otherwise, or (iii) publicly
                                            announce any intention to effect any transaction specified in clause (i) or (ii). Each of
                                            the Sponsor, directors and officers acknowledges and agrees that, prior to the effective
                                            date of any release or waiver, of the restrictions set forth in this paragraph 3 or in the
                                            Securities Escrow Agreement (as defined below), the Company shall announce the impending
                                            release or waiver by press release through a major news service at least two business days
                                            before the effective date of the release or waiver. Any release or waiver granted shall only
                                            be effective two business days after the publication date of such press release. The provisions
                                            of this paragraph will not apply to any transfer permitted pursuant to the terms of the Securities
                                            Escrow Agreement provided that the transferee has agreed in writing to be bound by the same
                                            terms contained in this Letter Agreement.

 

    	2

     

    

 

		4.	In
                                            the event of the liquidation of the Trust Account, the Sponsor (the “Indemnitor”)
                                            agrees to indemnify and hold harmless the Company against any and all loss, liability, claim,
                                            damage and expense whatsoever (including, but not limited to, any and all legal or other
                                            expenses reasonably incurred in investigating, preparing or defending against any litigation,
                                            whether pending or threatened) to which the Company may become subject as a result of any
                                            claim by (i) any third party for services rendered or products sold to the Company or (ii)
                                            any prospective target business with which the Company has entered into, or discussed entering
                                            into, a written letter of intent, confidentiality or other similar agreement or Business
                                            Combination agreement (a “Target”); provided, however,
                                            that such indemnification of the Company by the Indemnitor (x) shall apply only to the extent
                                            necessary to ensure that such claims by a third party or a Target do not reduce the amount
                                            of funds in the Trust Account to below the lesser of (i) $10.18 per Offering Share and (ii)
                                            the actual amount per Offering Share held in the Trust Account as of the date of the liquidation
                                            of the Trust Account, if less than $10.18 per Offering Share is then held in the Trust Account
                                            due to reductions in the value of the trust assets, less taxes payable, (y) shall not apply
                                            to any claims by a third party or a Target which executed a waiver of any and all rights
                                            to the monies held in the Trust Account (whether or not such waiver is enforceable) and (z)
                                            shall not apply to any claims under the Company’s indemnity of the Underwriters against
                                            certain liabilities, including liabilities under the Securities Act of 1933, as amended.
                                            The Indemnitor shall have the right to defend against any such claim with counsel of its
                                            choice reasonably satisfactory to the Company if, within 15 days following written receipt
                                            of notice of the claim to the Indemnitor, the Indemnitor notifies the Company in writing
                                            that it shall undertake such defense.

 

		5.	To
                                            the extent that the Underwriters do not exercise their over-allotment option to purchase
                                            up to an additional 900,000 Units within 45 days from the date of the Prospectus (and as
                                            further described in the Prospectus), the Initial Shareholders agree to forfeit, at no cost,
                                            a number of Founder Shares, to be split pro rata between them based on the number of Founder
                                            Shares they hold upon the consummation of the Public Offering, equal to 225,000 multiplied
                                            by a fraction, (i) the numerator of which is 1,725,000 minus the number of Units purchased
                                            by the Underwriters upon the exercise of their over-allotment option, and (ii) the denominator
                                            of which is 1,725,000. The forfeiture will be adjusted to the extent that the over-allotment
                                            option is not exercised in full by the Underwriters so that the Founder Shares will represent
                                            an aggregate of 20.0% of the Company’s issued and outstanding Ordinary Shares after
                                            the Public Offering (not including Ordinary Shares underlying the Private Placement Units
                                            (as defined below)). The Initial Shareholders further agree that to the extent that the size
                                            of the Public Offering is increased or decreased, the Company will purchase or sell Units
                                            or effect a share repurchase or share capitalization, as applicable, immediately prior to
                                            the consummation of the Public Offering in such amount as to maintain the ownership of the
                                            Initial Shareholders prior to the Public Offering at 20.0% of its issued and outstanding
                                            Capital Shares upon the consummation of the Public Offering. In connection with such increase
                                            or decrease in the size of the Public Offering, then (A) the references to 1,725,000 in the
                                            numerator and denominator of the formula in the first sentence of this paragraph shall be
                                            changed to a number equal to 15% of the number of Public Shares included in the Units issued
                                            in the Public Offering and (B) the reference to 225,000 in the formula set forth in the first
                                            sentence of this paragraph shall be adjusted to such number of Founder Shares that the Initial
                                            Shareholders would have to surrender to the Company in order for the Initial Shareholders
                                            to hold an aggregate of 20.0% of the Company’s issued and outstanding Ordinary Shares
                                            after the Public Offering (not including Ordinary Shares underlying the Warrants, Rights
                                            or Private Placement Units).

 

		6.	The
                                            Sponsor and each Insider hereby agrees and acknowledges that: (i) the Underwriters and the
                                            Company would be irreparably injured in the event of a breach by such Sponsor or an Insider
                                            of its, his or her obligations under paragraphs 1, 2, 3, 4, 5, 7, 8, 9, 10 and 11, as applicable,
                                            of this Letter Agreement, (ii) monetary damages may not be an adequate remedy for such breach
                                            and (iii) the non- breaching party shall be entitled to injunctive relief, in addition to
                                            any other remedy that such party may have in law or in equity, in the event of such breach.

 

    	3

     

    

 

		7.	The
                                            Sponsor and each Insider agrees that it, he or she shall place into escrow all of its, his
                                            or her Founder Shares and Private Placement Units pursuant to the terms of a Securities Escrow
                                            Agreement which the Company will enter into with each of the undersigned, as applicable,
                                            and an escrow agent acceptable to the Company (the “Securities Escrow Agreement”).
                                            Pursuant to the terms of the Securities Escrow Agreement, the Founder Shares and Private
                                            Placement Units (and underlying securities) held by the Sponsor and each Insider will not,
                                            subject to certain exceptions, be transferred, assigned, sold or released from escrow in
                                            the case of (i) 50% of the Founder Shares and Private Placement Units (and underlying securities)
                                            until the earlier to occur of: (A) six months after the date of the consummation of the Company’s
                                            initial Business Combination, or (B) the date on which the closing price of the Ordinary
                                            Shares equals or exceeds $12.50 per share (as adjusted for share splits, share dividends,
                                            reorganizations and recapitalizations) for any 20 trading days within any 30-trading day
                                            period commencing after the Company’s initial Business Combination and (ii) the remaining
                                            50% of the Founder Shares and Private Placement Units (and underlying securities) until six
                                            months after the date of the consummation of the Company’s initial Business Combination,
                                            or earlier, in either case, if, subsequent to the Company’s initial Business Combination,
                                            the Company consummates a subsequent liquidation, merger, share exchange or other similar
                                            transaction which results in all of the Company’s shareholders having the right to
                                            exchange their shares for cash, securities or other property.

 

		8.	Each
                                            Insider agrees to be a director or officer of the Company, as applicable, until the earlier
                                            of the consummation by the Company of a Business Combination or the liquidation of the Company.
                                            Each Insider’s biographical information furnished to the Company (including any such
                                            information included in the Prospectus) is true and accurate in all respects and does not
                                            omit any material information with respect to the Insider’s background and contains
                                            all of the information required to be disclosed pursuant to Item 401 of Regulation S-K, promulgated
                                            under the Securities Act of 1933, as amended (the “Securities Act”).
                                            The Sponsor and each Insider’s FINRA questionnaire and director and officer questionnaire
                                            furnished to the Company and the Representative is true and accurate in all respects. The
                                            Sponsor and each Insider represents and warrants that it, he or she:

 

(a) has
never had a petition under the federal bankruptcy laws or any state insolvency law been filed by or against (i) him or any partnership
in which he was a general partner at or within two years before the time of filing; or (ii) any corporation or business association of
which he was an executive officer at or within two years before the time of such filing;

 

(b) has
never had a receiver, fiscal agent or similar officer appointed by a court for his business or property, or any such partnership;

 

 (c) has never been convicted of fraud in a civil or criminal proceeding;

 

(d) has
never been convicted in a criminal proceeding or named the subject of a pending criminal proceeding (excluding traffic violations and
minor offenses);

 

(e) has
never been the subject of any order, judgment or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction,
permanently or temporarily enjoining or otherwise limiting him from (i) acting as a futures commission merchant, introducing broker,
commodity trading advisor, commodity pool operator, floor broker, leverage transaction merchant, any other person regulated by the Commodity
Futures Trading Commission (“CFTC”) or an associated person of any of the foregoing, or as an investment adviser, underwriter,
broker or dealer in securities, or as an affiliated person, director or employee of any investment company, bank, savings and loan association
or insurance company, or from engaging in or continuing any conduct or practice in connection with any such activity; or (ii) engaging
in any type of business practice; or (iii) engaging in any activity in connection with the purchase or sale of any security or commodity
or in connection with any violation of federal or state securities or federal commodities laws;

 

(f) has
never been the subject of any order, judgment or decree, not subsequently reversed, suspended or vacated, of any federal or state authority
barring, suspending or otherwise limiting for more than 60 days his right to engage in any activity described in paragraph 7(e)(i) above,
or to be associated with persons engaged in any such activity;

 

    	4

     

    

 

(g) has
never been found by a court of competent jurisdiction in a civil action or by the SEC to have violated any federal or state securities
law, where the judgment in such civil action or finding by the SEC has not been subsequently reversed, suspended or vacated;

 

(h) has
never been found by a court of competent jurisdiction in a civil action or by the CFTC to have violated any federal commodities law,
where the judgment in such civil action or finding by the CFTC has not been subsequently reversed, suspended or vacated;

 

(i) has
never been the subject of, or a party to, any federal or state judicial or administrative order, judgment, decree or finding, not subsequently
reversed, suspended or vacated, relating to an alleged violation of (i) any federal or state securities or commodities law or regulation,
(ii) any law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary or permanent
injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease and desist order, or removal or
prohibition order or (iii) any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity;

 

(j) has
never been the subject of, or party to, any sanction or order, not subsequently reversed, suspended or vacated, or any self-regulatory
organization, any registered entity, or any equivalent exchange, association, entity or organization that has disciplinary authority
over its members or persons associated with a member;

 

(k) has
never been convicted of any felony or misdemeanor: (i) in connection with the purchase or sale of any security; (ii) involving the making
of any false filing with the SEC; or (iii) arising out of the conduct of the business of an underwriter, broker, dealer, municipal securities
dealer, investment advisor or paid solicitor of purchasers of securities;

 

(l) was
never subject to a final order of a state securities commission (or an agency of officer of a state performing like functions); a state
authority that supervises or examines banks, savings associations, or credit unions; a state insurance commission (or an agency or officer
of a state performing like functions); an appropriate federal banking agency; the CFTC; or the National Credit Union Administration that
is based on a violation of any law or regulation that prohibits fraudulent, manipulative, or deceptive conduct;

 

(m) has
never been subject to any order, judgment or decree of any court of competent jurisdiction, that, at the time of such sale, restrained
or enjoined him from engaging or continuing to engage in any conduct or practice: (i) in connection with the purchase or sale of any
security; (ii) involving the making of any false filing with the SEC; or (iii) arising out of the conduct of the business of an underwriter,
broker, dealer, municipal securities dealer, investment adviser or paid solicitor of purchasers of securities;

 

(n) has
never been subject to any order of the SEC that orders him to cease and desist from committing or causing a future violation of: (i)
any scienter-based anti-fraud provision of the federal securities laws, including, but not limited to, Section 17(a)(1) of the Securities
Act, Section 10(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and Rule 10b-5 thereunder,
and Section 206(1) of the Investment Advisers Act of 1940, as amended (the “Advisers Act”) or any other rule
or regulation thereunder; or (ii) Section 5 of the Securities Act;

 

(o) has
never been named as an underwriter in any registration statement or Regulation A offering statement filed with the SEC that was the subject
of a refusal order, stop order, or order suspending the Regulation A exemption, or is, currently, the subject of an investigation or
proceeding to determine whether a stop order or suspension order should be issued;

 

(p) has
never been subject to a United States Postal Service false representation order, or is currently subject to a temporary restraining order
or preliminary injunction with respect to conduct alleged by the United States Postal Service to constitute a scheme or device for obtaining
money or property through the mail by means of false representations;

 

    	5

     

    

 

(q) is
not subject to a final order of a state securities commission (or an agency of officer of a state performing like functions); a state
authority that supervises or examines banks, savings associations, or credit unions; a state insurance commission (or an agency or officer
of a state performing like functions); an appropriate federal banking agency; the CFTC; or the National Credit Union Administration that
bars the undersigned from: (i) association with an entity regulated by such commission, authority, agency or officer; (ii) engaging in
the business of securities, insurance or banking; or (iii) engaging in savings association or credit union activities;

 

(r) is
not subject to an order of the SEC entered pursuant to section 15(b) or 15B(c) of the Exchange Act or section 203(e) or 203(f) of the
Advisers Act that: (i) suspends or revokes the undersigned’s registration as a broker, dealer, municipal securities dealer or investment
adviser; (ii) places limitations on the activities, functions or operations of, or imposes civil money penalties on, such person; or
(iii) bars the undersigned from being associated with any entity or from participating in the offering of any penny stock; and

 

(s) has
never been suspended or expelled from membership in, or suspended or barred from association with a member of, a securities self-regulatory
organization (e.g., a registered national securities exchange or a registered national or affiliated securities association) for any
act or omission to act constituting conduct inconsistent with just and equitable principles of trade.

 

		9.	Except
                                            as disclosed in the Prospectus, neither the Sponsor nor any officer, nor any affiliate of
                                            the Sponsor or any officer, nor any director of the Company, shall receive from the Company
                                            any finder’s fee, reimbursement, consulting fee, monies in respect of any repayment
                                            of a loan or other compensation prior to, or in connection with any services rendered in
                                            order to effectuate, the consummation of the Company’s initial Business Combination
                                            (regardless of the type of transaction that it is), other than the following, none of which
                                            will be made from the proceeds held in the Trust Account prior to the completion of the initial
                                            Business Combination: repayment of a loan and advances up to an aggregate of $300,000 made
                                            to the Company by the Sponsor; reimbursement for any reasonable out-of-pocket expenses related
                                            to identifying, investigating, negotiating and completing an initial Business Combination,
                                            and repayment of loans, if any, and on such terms as to be determined by the Company from
                                            time to time, made by the Sponsor or an affiliate of the Sponsor or any of the Company’s
                                            officers or directors to finance transaction costs in connection with an intended initial
                                            Business Combination, provided, that, if the Company does not consummate an initial Business
                                            Combination, a portion of the working capital held outside the Trust Account may be used
                                            by the Company to repay such loaned amounts so long as no proceeds from the Trust Account
                                            are used for such repayment. Up to $300,000 of such loans may be convertible into working
                                            capital units at a price of $10.00 per unit at the option of the lender. The working capital
                                            units would be identical to the Private Placement Units, each consisting of one ordinary
                                            share and one private warrant with the same exercise price, exercisability and exercise period,
                                            subject to similar limited restrictions as compared to the units sold in the initial public
                                            offering.
	 	 	 
		10.	The
                                            Sponsor and each Insider has full right and power, without violating any agreement to which
                                            it is bound (including, without limitation, any non-competition or non-solicitation agreement
                                            with any employer or former employer), to enter into this Letter Agreement and, as applicable,
                                            to serve as an officer and/or director on the board of directors of the Company and hereby
                                            consents to being named in the Prospectus as an officer and/or director of the Company.
	 	 	 
		11.	The
                                            Sponsor and each Insider acknowledges and agrees that prior to the Company entering into
                                            a Business Combination with a target business that is affiliated with the Sponsor, any Insider
                                            or any of their respective affiliates, including any company that is a portfolio company
                                            of, or otherwise affiliated with, or has received financial investment from, an entity with
                                            which the Sponsor, any Insider or any of their respective affiliates is affiliated, such
                                            transaction must be approved by a majority of the Company’s disinterested independent
                                            directors and the Company must obtain an opinion from an independent investment banking firm
                                            that is a member of the Financial Industry Regulatory Authority (“FINRA”),
                                            or from an independent accounting firm, that such Business Combination is fair to the Company’s
                                            unaffiliated stockholders from a financial point of view.

 

    	6

     

    

 

		12.	As
                                            used herein, (i) “Business Combination” shall mean a merger, share
                                            exchange, asset acquisition, share purchase, reorganization or similar business combination,
                                            involving the Company and one or more businesses; (ii) “Ordinary Shares”
                                            shall mean the Company’s Ordinary Shares (iii) “Founder Shares”
                                            shall mean the 1,725,000 Ordinary Shares issued and outstanding (up to 225,000 of which are
                                            subject to complete or partial forfeiture if the over-allotment option is not exercised by
                                            the Underwriters); (iv) “Initial Shareholders” shall mean the Sponsor
                                            and any Insider that holds Founder Shares; (v) “Private Placement Units”
                                            shall mean the 370,500 units (or 409,200 units if the over-allotment option is exercised
                                            in full) that the Sponsor has agreed to purchase for an aggregate purchase price of $3,705,000
                                            (or $4,092,000 if the over-allotment option is exercised in full), or $10.00 per unit, in
                                            a private placement that shall occur simultaneously with the consummation of the Public Offering;
                                            (vi) “Public Shareholders” shall mean the holders of securities
                                            issued in the Public Offering; (vii) “Trust Account” shall mean
                                            the trust fund into which a portion of the net proceeds of the Public Offering and the sale
                                            of the Private Placement Units shall be deposited; and (viii) “Transfer”
                                            shall mean the (a) sale of, offer to sell, contract or agreement to sell, hypothecate, pledge,
                                            grant of any option to purchase or otherwise dispose of or agreement to dispose of, directly
                                            or indirectly, or establishment or increase of a put equivalent position or liquidation with
                                            respect to or decrease of a call equivalent position within the meaning of Section 16 of
                                            the Exchange Act, and the rules and regulations of the Commission promulgated thereunder
                                            with respect to, any security, (b) entry into any swap or other arrangement that transfers
                                            to another, in whole or in part, any of the economic consequences of ownership of any security,
                                            whether any such transaction is to be settled by delivery of such securities, in cash or
                                            otherwise, or (c) public announcement of any intention to effect any transaction specified
                                            in clause (a) or (b).
	 	 	 
		13.	The
                                            Company will maintain an insurance policy or policies providing directors’ and officers’
                                            liability insurance, and each Director shall be covered by such policy or policies, in accordance
                                            with its or their terms, to the maximum extent of the coverage available for any of the Company’s
                                            directors or officers.
	 	 	 
		14.	This
                                            Letter Agreement constitutes the entire agreement and understanding of the parties hereto
                                            in respect of the subject matter hereof and supersedes all prior understandings, agreements,
                                            or representations by or among the parties hereto, written, or oral, to the extent they relate
                                            in any way to the subject matter hereof or the transactions contemplated hereby. This Letter
                                            Agreement may not be changed, amended, modified, or waived (other than to correct a typographical
                                            error) as to any particular provision, except by a written instrument executed by all parties
                                            hereto.
	 	 	 
		15.	No
                                            party hereto may assign either this Letter Agreement or any of its rights, interests, or
                                            obligations hereunder without the prior written consent of the other parties. Any purported
                                            assignment in violation of this paragraph shall be void and ineffectual and shall not operate
                                            to transfer or assign any interest or title to the purported assignee. This Letter Agreement
                                            shall be binding on the Sponsor and each Insider and their respective successors, heirs and
                                            assigns and permitted transferees.
	 	 	 
		16.	Nothing
                                            in this Letter Agreement shall be construed to confer upon, or give to, any person or corporation
                                            other than the parties hereto any right, remedy or claim under or by reason of this Letter
                                            Agreement or of any covenant, condition, stipulation, promise or agreement hereof. All covenants,
                                            conditions, stipulations, promises, and agreements contained in this Letter Agreement shall
                                            be for the sole and exclusive benefit of the parties hereto and their successors, heirs,
                                            personal representatives and assigns and permitted transferees.
	 	 	 
		17.	This
                                            Letter Agreement may be executed in any number of original or facsimile counterparts and
                                            each of such counterparts shall for all purposes be deemed to be an original, and all such
                                            counterparts shall together constitute but one and the same instrument.
	 	 	 
		18.	This
                                            Letter Agreement shall be deemed severable, and the invalidity or unenforceability of any
                                            term or provision hereof shall not affect the validity or enforceability of this Letter Agreement
                                            or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable
                                            term or provision, the parties hereto intend that there shall be added as a part of this
                                            Letter Agreement a provision as similar in terms to such invalid or unenforceable provision
                                            as may be possible and be valid and enforceable.

 

    	7

     

    

 

		19.	This
                                            Letter Agreement shall be governed by and construed and enforced in accordance with the laws
                                            of the State of New York. The parties hereto (i) all agree that any action, proceeding, claim
                                            or dispute arising out of, or relating in any way to, this Letter Agreement shall be brought
                                            and enforced in the courts of New York City, in the State of New York, and irrevocably submit
                                            to such jurisdiction and venue, which jurisdiction and venue shall be exclusive and (ii)
                                            waive any objection to such exclusive jurisdiction and venue or that such courts represent
                                            an inconvenient forum.
	 	 	 
		20.	Any
                                            notice, consent, or request to be given in connection with any of the terms or provisions
                                            of this Letter Agreement shall be in writing and shall be sent by express mail or similar
                                            private courier service, by certified mail (return receipt requested), by hand delivery or
                                            facsimile transmission.
	 	 	 
		21.	The
                                            Sponsor and each Insider acknowledges and understands that the Underwriters and the Company
                                            will rely upon the agreements, representations and warranties set forth herein in proceeding
                                            with the Public Offering. Nothing contained herein shall be deemed to render the Underwriters
                                            a representative of, or a fiduciary with respect to, the Company, its stockholders or any
                                            creditor or vendor of the company with respect to the subject matter hereof.

 

[Signature
Page Follows]

 

    	8

     

    

 

	 	Sincerely,
	 	 	 
	 	ALPHAMADE HOLDING LP
	 	 	 
	 	By: 	/s/ Taylor Zhang
	 	Name:	Taylor Zhang
	 	Title:	Manager
	 	 	 
	 	DIRECTORS
    AND OFFICERS
	 	 	 
	 	/s/
    Xinfeng Feng
	 	Name:	Xinfeng Feng
	 	 	 
	 	/s/ Dajiang Guo
	 	Dajiang Guo
	 	 	 
	 	/s/ Jichuan Yang
	 	Jichuan Yang
	 	 	 
	 	/s/ Li Wei 
	 	Li Wei
	 	 	 
	 	/s/ Michael Coyne
	 	Michael Coyne
	 	 	 
	 	/s/ Wen He
	 	Wen He

 

	Acknowledged and Agreed:	 
	ALPHATIME ACQUISITION CORP	 
	 	 	 
	By:	/s/ Xinfeng Feng	 
	Name:	Xinfeng Feng 	 
	Title:	Chairwoman	 

 

    	9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00351-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00351-of-00352.parquet"}]]